| http://www.w3.org/ns/prov#value | - The transaction, valued at approximately $239 million, is subject to the valid tender of a majority of Lifecore Biomedical???s fully diluted common shares, regulatory approvals and other customary conditions, but is not subject to any financing condition.
|
